Cargando…

Low-grade central fibroblastic osteosarcoma may be differentiated from its mimicker desmoplastic fibroma by genetic analysis

BACKGROUND: We studied two cases of rare fibrous bone tumors, namely desmoplastic fibroma (DF) and low-grade central osteosarcoma (LGCOS) resembling desmoplastic fibroma (DF-like LGCOS). As the clinical presentation, imaging features and histopathology of DF and DF-like LGOS show much overlap, the o...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Wangzhao, van den Berg, Eva, Kwee, Thomas C., Jutte, Paul C., Cleton-Jansen, Anne-Marie, Bovée, Judith V. M. G., Suurmeijer, Albert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6106748/
https://www.ncbi.nlm.nih.gov/pubmed/30159138
http://dx.doi.org/10.1186/s13569-018-0104-z
Descripción
Sumario:BACKGROUND: We studied two cases of rare fibrous bone tumors, namely desmoplastic fibroma (DF) and low-grade central osteosarcoma (LGCOS) resembling desmoplastic fibroma (DF-like LGCOS). As the clinical presentation, imaging features and histopathology of DF and DF-like LGOS show much overlap, the objective of this study was to investigate the value of cytogenetic analysis, molecular pathology and immunohistochemistry in discrimination of these two mimickers. CASE PRESENTATION: A mutation in CTNNB (S45F) and nuclear beta-catenin immunostaining were observed in DF. DF-LGCOS had amplification of CDK4 and showed strong nuclear expression of CDK4 by IHC. Moreover, the karyotype of DF-LGCOS showed an interstitial heterozygous deletion of the long arm of chromosome 13 (q12q32), associated with loss of the RB1 tumor suppressor gene. CONCLUSIONS: Karyotyping and molecular genetic analysis may contribute to a conclusive diagnosis.